IN8bio, Inc.INABNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-10.1%
5Y CAGR+13.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-10.1%/yr
vs +121.8%/yr prior
5Y CAGR
+13.7%/yr
Recent deceleration
Acceleration
-131.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.21M | -39.8% |
| 2024 | $16.96M | +0.8% |
| 2023 | $16.83M | +19.7% |
| 2022 | $14.06M | +91.4% |
| 2021 | $7.35M | +36.6% |
| 2020 | $5.38M | +128.1% |
| 2019 | $2.36M | +305.9% |
| 2018 | $581000.00 | - |